Showing results (31-40 of 419) with videos related to
Sort By:
Pageof 42
Drug Safety|May 1, 1991
Risk-benefit assessment of drugs used in the treatment of inflammatory bowel diseaseS B Hanauer, G StathopoulosThe American Journal of Gastroenterology|April 1, 1997
Management of Crohn's disease in adultsS B Hanauer, S MeyersGastroenterologie Clinique Et Biologique|February 2, 2010
Conventional treatment in inflammatory bowel disease--recent trends. Immunosuppressants and biologic agents: should they or need they be used together? How to use immunosuppressive therapy better (and safer) tomorrow?Y Leung, S B HanauerAnnual Review of Medicine|February 13, 2001
Evolving treatment strategies for inflammatory bowel diseaseS B Hanauer, T DassopoulosBest Practice & Research. Clinical Gastroenterology|February 28, 2002
Assessing and interviewing the elderly: interpretation of signs and symptomsM Sklar, J B KirsnerInflammatory Bowel Diseases|May 25, 1999
Antitumor necrosis factor therapy for inflammatory bowel disease: a review of agents, pharmacology, clinical results, and safetyW J Sandborn, S B HanauerThe American Journal of Gastroenterology|May 16, 2000
Medical therapy to reduce postoperative Crohn's disease recurrenceJ P Achkar, S B HanauerSeminars in Gastrointestinal Disease|April 21, 1998
Medical management of perianal Crohn's diseaseA M Winter, S B HanauerGastroenterology Clinics of North America|September 1, 1995
New therapeutic approachesS B Hanauer, M I SchulmanPageof 42